148 related articles for article (PubMed ID: 38632333)
1. A multi-cancer early detection blood test using machine learning detects early-stage cancers lacking USPSTF-recommended screening.
Vittone J; Gill D; Goldsmith A; Klein EA; Karlitz JJ
NPJ Precis Oncol; 2024 Apr; 8(1):91. PubMed ID: 38632333
[TBL] [Abstract][Full Text] [Related]
2. Estimating the population health impact of a multi-cancer early detection genomic blood test to complement existing screening in the US and UK.
Hackshaw A; Cohen SS; Reichert H; Kansal AR; Chung KC; Ofman JJ
Br J Cancer; 2021 Nov; 125(10):1432-1442. PubMed ID: 34426664
[TBL] [Abstract][Full Text] [Related]
3. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set.
Klein EA; Richards D; Cohn A; Tummala M; Lapham R; Cosgrove D; Chung G; Clement J; Gao J; Hunkapiller N; Jamshidi A; Kurtzman KN; Seiden MV; Swanton C; Liu MC
Ann Oncol; 2021 Sep; 32(9):1167-1177. PubMed ID: 34176681
[TBL] [Abstract][Full Text] [Related]
4. Multi-year clinical outcomes of cancers diagnosed following detection by a blood-based multi-cancer early detection (MCED) test.
Buchanan AH; Lennon AM; Choudhry OA; Elias PZ; Rego SP; Sadler JR; Roberta J; Zhang Y; Flake DD; Salvati ZM; Wagner ES; Fishman EK; Papadopoulos N; Beer TM
Cancer Prev Res (Phila); 2024 May; ():. PubMed ID: 38819783
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of Blood-Based Multi-cancer Detection in Plasma Cell-Free DNA.
Chen X; Dong Z; Hubbell E; Kurtzman KN; Oxnard GR; Venn O; Melton C; Clarke CA; Shaknovich R; Ma T; Meixiong G; Seiden MV; Klein EA; Fung ET; Liu MC
Clin Cancer Res; 2021 Aug; 27(15):4221-4229. PubMed ID: 34088722
[TBL] [Abstract][Full Text] [Related]
6. Addressing positive multi-cancer early detection tests in head and neck Surgery: Experience with head and neck work up for high-risk referrals.
Fearington FW; Zhao CY; Romero-Brufau S; Moore EJ; Price DL; Tasche KK; Yin LX; Kunkel ET; Kisiel JB; Giridhar KV; Routman DM; Van Abel KM
Oral Oncol; 2024 May; 152():106809. PubMed ID: 38621326
[TBL] [Abstract][Full Text] [Related]
7. The Potential Value-Based Price of a Multi-Cancer Early Detection Genomic Blood Test to Complement Current Single Cancer Screening in the USA.
Tafazzoli A; Ramsey SD; Shaul A; Chavan A; Ye W; Kansal AR; Ofman J; Fendrick AM
Pharmacoeconomics; 2022 Nov; 40(11):1107-1117. PubMed ID: 36038710
[TBL] [Abstract][Full Text] [Related]
8. An Exploratory Analysis of the Cost-Effectiveness of a Multi-cancer Early Detection Blood Test Compared with Standard of Care Screening in Ontario, Canada.
Lewis D; Wong WWL; Lipscomb J; Horton S
Pharmacoeconomics; 2024 Apr; 42(4):393-407. PubMed ID: 38150120
[TBL] [Abstract][Full Text] [Related]
9. Patient Preferences for Multi-Cancer Early Detection (MCED) Screening Tests.
Gelhorn H; Ross MM; Kansal AR; Fung ET; Seiden MV; Krucien N; Chung KC
Patient; 2023 Jan; 16(1):43-56. PubMed ID: 35844011
[TBL] [Abstract][Full Text] [Related]
10. Association of Breast Cancer Screening Behaviors With Stage at Breast Cancer Diagnosis and Potential for Additive Multi-Cancer Detection
Hathaway C; Paetsch P; Li Y; Wu J; Asgarian S; Parker A; Welsh A; Deverka P; Cohain A
Front Oncol; 2021; 11():688455. PubMed ID: 34222015
[TBL] [Abstract][Full Text] [Related]
11. Attitudes to multi-cancer early detection (MCED) blood tests for population-based screening: A qualitative study in Great Britain.
Schmeising-Barnes N; Waller J; Marlow LAV
Soc Sci Med; 2024 Apr; 347():116762. PubMed ID: 38520825
[TBL] [Abstract][Full Text] [Related]
12. Projecting the Impact of Multi-Cancer Early Detection on Late-Stage Incidence Using Multi-State Disease Modeling.
Lange JM; Gogebakan KC; Gulati R; Etzioni R
Cancer Epidemiol Biomarkers Prev; 2024 Jun; 33(6):830-837. PubMed ID: 38506751
[TBL] [Abstract][Full Text] [Related]
13. Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study.
Nicholson BD; Oke J; Virdee PS; Harris DA; O'Doherty C; Park JE; Hamady Z; Sehgal V; Millar A; Medley L; Tonner S; Vargova M; Engonidou L; Riahi K; Luan Y; Hiom S; Kumar H; Nandani H; Kurtzman KN; Yu LM; Freestone C; Pearson S; Hobbs FR; Perera R; Middleton MR
Lancet Oncol; 2023 Jul; 24(7):733-743. PubMed ID: 37352875
[TBL] [Abstract][Full Text] [Related]
14. Circulating cell-free DNA-based multi-cancer early detection.
Zhang K; Fu R; Liu R; Su Z
Trends Cancer; 2024 Feb; 10(2):161-174. PubMed ID: 37709615
[TBL] [Abstract][Full Text] [Related]
15. The Promise of Multicancer Early Detection. Comment on Pons-Belda et al. Can Circulating Tumor DNA Support a Successful Screening Test for Early Cancer Detection? The Grail Paradigm.
Klein EA; Beer TM; Seiden M
Diagnostics (Basel); 2022 May; 12(5):. PubMed ID: 35626398
[TBL] [Abstract][Full Text] [Related]
16. Integrating primary care, shared decision making, and community engagement to facilitate equitable access to multi-cancer early detection clinical trials.
Thompson CL; Buchanan AH; Myers R; Weinberg DS
Front Oncol; 2023; 13():1307459. PubMed ID: 38486933
[TBL] [Abstract][Full Text] [Related]
17. Circulating Tumor DNA Allele Fraction: A Candidate Biological Signal for Multicancer Early Detection Tests to Assess the Clinical Significance of Cancers.
Bredno J; Venn O; Chen X; Freese P; Ofman JJ
Am J Pathol; 2022 Oct; 192(10):1368-1378. PubMed ID: 35948080
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of cell-free DNA approaches for multi-cancer early detection.
Jamshidi A; Liu MC; Klein EA; Venn O; Hubbell E; Beausang JF; Gross S; Melton C; Fields AP; Liu Q; Zhang N; Fung ET; Kurtzman KN; Amini H; Betts C; Civello D; Freese P; Calef R; Davydov K; Fayzullina S; Hou C; Jiang R; Jung B; Tang S; Demas V; Newman J; Sakarya O; Scott E; Shenoy A; Shojaee S; Steffen KK; Nicula V; Chien TC; Bagaria S; Hunkapiller N; Desai M; Dong Z; Richards DA; Yeatman TJ; Cohn AL; Thiel DD; Berry DA; Tummala MK; McIntyre K; Sekeres MA; Bryce A; Aravanis AM; Seiden MV; Swanton C
Cancer Cell; 2022 Dec; 40(12):1537-1549.e12. PubMed ID: 36400018
[TBL] [Abstract][Full Text] [Related]
19. Clinical performance and utility: A microsimulation model to inform the design of screening trials for a multi-cancer early detection test.
Dai JY; Zhang J; Braun JV; Simon N; Hubbell E; Zhang N
J Med Screen; 2024 Feb; ():9691413241228041. PubMed ID: 38304990
[TBL] [Abstract][Full Text] [Related]
20. New genomic technologies for multi-cancer early detection: Rethinking the scope of cancer screening.
Hackshaw A; Clarke CA; Hartman AR
Cancer Cell; 2022 Feb; 40(2):109-113. PubMed ID: 35120599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
